Skip to content

Clinical trials

Observational Carcinoma, Bronchogenic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Bronchogenic Phase: Observational Country / region: France Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20171
20191
20202
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Unknown status2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Blueprint Medicines Corporation1
Centre Hospitalier Universitaire Dijon1
Centre Hospitalier de PAU1
RENAULT Patrick Aldo1
University Hospital, Brest1
University Hospital, Strasbourg, France1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Bronchogenic7
Carcinoma, Non-Small-Cell Lung2
Lung Diseases2
Lung Neoplasms2
Neoplasms by Site2
Respiratory Tract Diseases2
Respiratory Tract Neoplasms2
Thoracic Neoplasms2
Bronchial Diseases1
Bronchial Neoplasms1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.